Objective: Low grade chronic inflammation has been hypothesized to underlie the constellation of cardiometabolic risk factors, possibly by inducing insulin resistance. In the present study we investigated associations between inflammation markers, insulin sensitivity (M/I) and a range of cardiometabolic risk factors in a large, healthy population.
everal inflammation markers have been shown to be associated with cardiometabolic risk profile. A study in a diabetic population found that abnormalities of the immune system including elevated acute-phase reactants, interleukin-6 (IL-6), C-reactive protein (CRP) and cortisol were all associated with the metabolic syndrome (1) . The IRAS study showed in a non-diabetic population that white blood cell count (WBC), CRP and fibrinogen were all related to elements of the metabolic syndrome (2) . In a range of prospective studies, inflammation markers have also been shown to relate to the development of type 2 diabetes and coronary heart disease (CHD). The ARIC study reported associations between raised WBC, fibrinogen and low serum albumin and diagnosis of diabetes 7 years later in a large middle-aged population (3). In a large cohort study in patients undergoing angiography, the erythrocyte sedimentation rate (ESR) was related to coronary atherosclerosis and was a predictor of cardiac death in patients with probable ischemic heart disease (4). A metaanalysis of prospective studies investigating the relationship between inflammatory factors and subsequent coronary heart disease, found associations between fibrinogen, CRP, albumin and leukocyte count and the development of CHD (5).
Low grade inflammation may lead to cardiometabolic disease by inducing insulin resistance, a major contributor to the development of cardiovascular and metabolic disease. Insulin resistance has been shown to be associated with several inflammatory factors (2, 6, 7) . A prospective study in Pima Indians showed that a high WBC predicted development of diabetes, independent of body fat (8). The effect seemed to be mediated by a worsening of insulin sensitivity during the 5 years of follow-up.
Limitations of the existing literature on the association between low grade inflammation, insulin resistance and cardiometabolic disease include the lack of direct measurement of insulin sensitivity by the gold standard technique, the hyperinsulinaemic euglycaemic clamp, in a large healthy population. Often, fasting hyperinsulinaemia has been used as a surrogate measure of insulin sensitivity (6,7). However, among others, our group has shown that hyperinsulinaemia contributes to cardiovascular risk independently from insulin resistance as measured by the hyperinsulinaemic euglycaemic clamp (9). The question is whether low grade inflammation is associated with insulin sensitivity as measured by the hyperinsulinaemic euglycaemic clamp and whether clamp derived insulin resistance mediates the association between inflammation and cardiometabolic disease. In the present study we tried to answer these questions by using data from the Relationship between Insulin Sensitivity and Cardiovascular disease (RISC) study cohort.
RESEARCH DESIGN AND METHODS
Selection procedures: The RISC cohort consists of clinically healthy men and women aged between 30 and 60 years. Cohort members were recruited by 19 research centers in 14 European countries. Detailed information on inclusion can be found elsewhere (10). The local Medical Ethics committee of each participating research center approved the study. All participants gave written informed consent.
Measurements -basal: As indicators for cardiometabolic disease risk we included waist circumference, fat mass, fasting glucose, pro-insulin, insulin and C-peptide, 2h glucose and insulin, insulin resistance, high density lipoprotein (HDL) cholesterol, S inflammation, insulin and cardiometabolic risk triglycerides, systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate. We measured height on a clinic stadiometer, weight and fat-free mass with the TANITA bioimpedance balance (Tanita, UK) and waist circumference with a tape measure. Blood pressure and heart rate were measured three times by an automatic blood pressure measuring device (OMRON, The Netherlands). We used the median value of the three measurements. Fasting blood samples were taken to assess WBC, ESR and lipids. We performed a 75g oral glucose tolerance test (OGTT). A lifestyle and medical history questionnaire collected information on socioeconomic status, family history of diabetes, smoking and alcohol drinking habits and physical activity.
Measurements -Insulin sensitivity: On a separate day within one month of the OGTT, a hyperinsulinaemic euglycaemic clamp was performed in all participants included in the study. Fasting samples were taken to assess pro-insulin and C-peptide. Exogenous insulin was infused at a rate of 240 pmol•min -1 •m -2 simultaneously with a 20% dextrose infusion. Plasma glucose was measured at 5 to 10 min intervals to ensure it remained within 0.8 mmol/l (±15%) of the target glucose concentration (4.5-5.0 mmol/l). The steady state period for the calculation of the M value was between 80-120 min and normalized by the fat-free mass. Insulin sensitivity was expressed as the ratio of the M value to the mean plasma insulin concentrations measured during the final 40 minutes of the clamp (M/I) (9 12 /l) and ESR (>15 mm/h). Finally, we used multivariate linear regression analysis to study the associations between WBC, ESR, insulin sensitivity, and cardiometabolic risk factors. We ran four models: in the first model we adjusted for the basic variables age, smoking and study center; in the second model for the basic variables and waist; in the third model for the basic variables and M/I; in the fourth model for the basic variables, waist and M/I. In all other statistical models, we adjusted for age, smoking and study center. To make the resulting regression coefficients comparable, we report standardized betas.
RESULTS
Study group: A total of 1538 men and women participated in the RISC cohort.
Following the basal measurements, 180 cohort members not satisfying the inclusion criteria were excluded and 32 persons dropped out. We excluded another 13 participants, because both WBC and ESR values were missing. Of the resulting group of 1313 participants, 591 (45%) were men. The mean age of the study group was 43.8 (± 8.3) years.
WBC, ESR, general and lifestyle characteristics:
Median values and interquartile ranges of WBC were 5.5 (2.2) ·10 12 /l in men and 5.8 (2.0) ·10 12 /l in women (P = 0.73 for difference). Median values and interquartile ranges of ESR were 5.0 (7.0) mm/h in men and 8.0 (8.0) mm/h in women (P < 0.01 for difference).
In men, there was a positive association between age and WBC which showed a trend towards significance (P = 0.07), while in women the association was statistically significant (P < 0.01). Smoking status (P < 0.01) was significantly and positively associated with WBC in men and women. Study center was associated with WBC in men only (P < 0.01). ESR was significantly associated with study center (P < 0.01) and negatively associated with alcohol intake (P < 0.01) in both men and women. Medians of WBC for the different study centers ranged from 4.5 to 7.4 ·10 12 /l in men and from 4.9 to 6.4 ·10 12 /l in women. Medians of ESR ranged from 2.0 to 9.0 mm/h in men and from 5.0 to 15.0 mm/h in women. WBC and ESR were significantly correlated with each other, in men (ρ = .14, P = 0.00) stronger than in women (ρ = .08, P = 0.04).
WBC, ESR and M/I: WBC was negatively correlated with M/I in both men (ρ = -.19, P = 0.00) and women (ρ = -.10, P = 0.01) ( Table 2 ). Per unit increase in WBC, M/I decreased by 6.7% (95% CI: 4.2 to 9.3, adjusted for age, study center and smoking) in men and by 4.3% (2.1 to 6.5) in women. Additionally adjusting for waist led to a M/I decrease of 4.5% (2.1 to 6.8) per unit WBC in men and 3.2 % (1.0 to 5.3) in women.
ESR was also negatively correlated with M/I in men (ρ = -.27, P = 0.00) and women (ρ = -.21, P = 0.00) ( Table 3) . M/I decreased by 2.1% (95% CI: 1.3 to 2.9) per unit increase in ESR in men and by 1.2% (0.8 to 1.6) in women. Adjusted for waist the decrease was 1.3% (0.6 to 2.0) in men and 0.9% (0.5 to 1.3) in women WBC, cardiometabolic risk factors and M/I: Correlations between WBC and all cardiometabolic risk factors except SBP, DBP, fasting glucose in both men and women and 2h glucose in men were significant (Table  2) . Overall, correlations were stronger in men than in women. In a multivariate regression model, WBC was a statistically significant predictor variable for waist, fat mass, HDL cholesterol, triglycerides, heart rate, 2h glucose, fasting C-peptide, pro-insulin and insulin, 2h insulin and M/I in men and in women and also for DBP in women (adjusted for age, study center and smoking). After adding M/I to the regression model, associations between WBC and 2h glucose and fasting pro-insulin in men and between WBC and DBP in women became statistically non-significant. Associations between WBC and HDL cholesterol, triglycerides, heart rate, fasting C-peptide and insulin and 2h insulin in men and women and between WBC and 2h glucose in women remained significant after adjusting for both M/I and waist.
ESR, cardiometabolic risk factors and M/I: Correlations between ESR and all cardiometabolic risk factors but fasting glucose in men and women and SBP, DBP, and fasting pro-insulin in men were significant (Table 3) . In a multivariable regression model, ESR was a statistically significant predictor variable for waist, fat mass, HDL cholesterol, triglycerides, heart rate, fasting C-peptide, pro-insulin and insulin, 2h insulin and M/I in men and women and for 2h glucose in men. When adding M/I to the regression model, associations between ESR and fasting pro-insulin in men and women and HDL cholesterol, 2h glucose, and fasting C-peptide in men became statistically non-significant. Associations between ESR and HDL cholesterol, heart rate, fasting and 2h insulin in men and women and between ESR and fat mass in women remained significant after adjusting for M/I and waist.
WBC, ESR, fasting insulin compared to M/I: Correlations between WBC and fasting insulin were stronger than those between WBC and M/I (men (ρ = .28, P = 0.00), women (ρ = .27, P = 0.00). Per unit increase in WBC, fasting insulin increased by 8.1% (5.4 to 10.8) in men and by 9.8% (7.3 to 12.3) in women. When we adjusted for waist and M/I the increase was 4.1% (1.7 to 6.4) in men and 7.0% (4.8 to 9.1) in women. Adjusted for waist and fasting insulin the decrease per unit WBC in M/I became statistically non-significant in both men (-1.8% [-0.5 to 4.0]) and women (-0.7% [-2.8 to
In men, the correlation between ESR and M/I was somewhat stronger than the correlation between ESR and fasting insulin (ρ = .23, P = 0.00). In women, it was the other way around (ρ = .26, P = 0.00). Per unit increase in ESR, fasting insulin increased by 2.2% (1.4 to 3.0) in men and 1.5% (1.0 to 2.0) in women; adjusted for waist and M/I the increase was 0.9% (0.3 to 1.6) in men and 0.6% (0.2 to 1.0) in women. When adjusting for waist and fasting insulin the decrease per unit WBC in M/I was 0.7% (0.1 to 1.4) in men and 0.6% (0.2 to 1.0) in women.
Additional analyses: To examine whether the associations between WBC, ESR and fasting C-peptide and pro-insulin could be explained by fasting insulin, we added fasting insulin to regression model 1. Results showed that associations between WBC, ESR and pro-insulin and between ESR and Cpeptide disappeared in both men and women. However, the association between WBC and fasting C-peptide remained (standardized β in men = 0.094, in women = 0.075).
Twenty-three participants had a WBC value above 10 ·10 12 /l and 190 participants had an ESR value above 15 mm/h. Exclusion of high WBC and ESR values had some effect on the size of the correlations with the cardiometabolic variables. However, except for the correlation between WBC and fasting C-peptide in men (P = 0.07) and correlations between ESR and SBP (P = 0.07) and DBP (P = 0.07) in women, all of the reported correlations remained statistically significant.
DISCUSSION
In a large, healthy European cohort we found that two general markers of inflammation, WBC and ESR, were associated with insulin sensitivity, as measured by the hyperinsulinaemic euglycaemic clamp, and with a wide range of other cardiometabolic risk factors.
Insulin resistance has been related to several inflammatory factors before (2,6,7). However, in these studies, fasting insulin has often been used as a surrogate measure of insulin resistance (6,7). We have now shown that insulin sensitivity as measured by the gold standard technique, hyperinsulinaemic euglycaemic clamp, is associated with inflammation. Also, we have shown that fasting hyperinsulinaemia is independently and at least as strongly associated with inflammation as insulin resistance. The RISC study has shown before that insulin resistance and hyperinsulinaemia are independent contributors to cardiovascular risk (9). These results are supported by Festa et al. who showed that fasting pro-insulin and insulin were related to fibrinogen and PAI-1, independently of insulin resistance as estimated by an intravenous glucose tolerance test (11).
When we adjusted for waist circumference, the associations between WBC, ESR and insulin resistance were reduced but remained strong. A number of proinflammatory cytokines are known to directly affect insulin sensitivity: TNF-alpha and leptin have been shown to affect insulin sensitivity in animal models, while IL-6 has been shown to induce insulin resistance in humans (12-14). Hypothetically, the inflammatory effect on fasting insulin concentrations could take place in the liver. Fasting hyperinsulinaemia has been suggested to reflect insulin resistance in the liver (15). IL-6 has been shown to inhibit insulin signaling in hepatocytes (16). Because of the cross-sectional nature of our date a reversed pathway is also possible: the state of insulin resistance and/or hyperinsulinaemia itself promotes inflammation. Insulin has an anti inflammatory effect in that it can lessen the acute-phase response (17). Insulin resistance may prevent the anti-inflammatory effect of insulin. Another possibility is that low grade inflammation, insulin resistance and hyperinsulinaemia are all manifestations of another underlying pathology, for example dysfunction of the autonomic nervous system as a consequence of a disturbed food and activity behavior pattern. This dysfunction has been hypothesized to underlie the metabolic syndrome and its precursors (18). However, an indirect pathway from inflammation to insulin resistance via obesity could also be possible. A body of evidence shows obesity causes inflammation. However, some data suggest the reverse to be also true: a state of chronic inflammation may be a causative factor in obesity (19).
Besides with insulin sensitivity and fasting insulin, both WBC and ESR showed consistent and strong associations with waist, fat mass, HDL cholesterol, triglycerides, heart rate, and 2h insulin in men and women. Associations between WBC, ESR and 2h glucose and DBP were less consistent and we found no associations between WBC, ESR and SBP and fasting glucose. The strong relations between WBC, ESR and the several cardiometabolic risk factors became somewhat smaller, but did not consistently disappear after adjusting for insulin resistance. Although the data are crosssectional, they suggest that a state of chronic low grade inflammation does not lead to the development of a pattern of high cardiometabolic risk via the inducement of insulin resistance. In stead, the associations seem to be of a direct nature. Most are supported by the literature. Infection and inflammation are well known to be associated with marked changes in lipid and lipoprotein metabolism (20) . An association between subclinical inflammation and elevated heart rate was found in a study of middle-aged and elderly persons without apparent heart disease (21). Interestingly, we also found an association between WBC and fasting Cpeptide, which did not disappear after adjusting for fasting insulin. A direct effect of inflammation on C-peptide is not known. However, since our observations are not of prospective nature, the direction of the associations could also be reversed. C-peptide has been found to induce monocyte chemotaxis in vitro and may play an active role in atherogenesis (22). Another association that could very well be reversed is that of inflammation and lipids. Evidence for a direct effect of lipids on the induction of a proinflammatory state is increasing. Among others, a study in which healthy males were subjected to a water test and a 6h fat challenge, showed that after fat, neutrophil counts and activation of monocytes and neutrophils were increased compared to water (23).
The relationship between smoking, alcohol and inflammation has long been known. Our study results confirm the major effect that smoking behavior has on inflammation: the number of smokers more than doubled in the highest quartile of WBC values compared to lower quartiles. Results from the present study also confirm that the use of alcohol reduces inflammation.
Our study has a number of limitations. Both WBC and ESR were not centrally determined by a single laboratory, possibly inducing measurement variability. Systematic differences between study centers were observed, but we adjusted for study centre in all analyses. Another drawback is that we had no information on possible infections in our participants that could have caused high WBC or ESR. However, removal of the clinically abnormal values of WBC and ESR had no major effect on the correlations between these markers and cardiometabolic variables. Also, WBC and ESR may be viewed as suboptimal markers of inflammation compared to the currently very popular marker CRP (which we did not measure). However, both WBC and ESR have frequently been shown to be associated with cardiometabolic abnormalities as well as the development of cardiometabolic disease and cardiovascular mortality (2) (3) (4) (5) 24, 25) . A further limitation is that due to the cross-sectional nature of our data we can draw no conclusions on causality and directionality of the associations we found. Finally, in observational studies, the interpretation of the observed associations and the changes in the model after adding additional variables is limited by chance and by imprecision of the measurements. In the present study, large efforts were taken to perform precise measurements of insulin resistance. Furthermore, all centers were centrally instructed on the measurements and central laboratories performed most assays. The consistent pattern observed, that the majority of the associations between the inflammation markers and cardiometabolic risk factors remained strong after adding M/I to the model and regression coefficients only slightly decreased, suggest that insulin resistance is not a large intermediary factor.
Besides the limitations, our study has some major advantages also. First, we measured inflammatory markers in a very large number of healthy participants. Second, we measured insulin sensitivity with the gold standard technique. Finally, we measured a wide range of cardiometabolic risk factors ranging from glucose concentrations to concentrations of C-peptide.
In conclusion, this study showed that low grade chronic inflammation is strongly associated with cardiometabolic risk in a healthy population. Insulin resistance, as measured by the hyperinsulinaemic euglycaemic clamp, seems to be one of these cardiometabolic risk factors rather than an intermediary factor in the relation between inflammation and other cardiometabolic risk factors. Data are means (SD), ‡ medians (interquartile range) and frequencies; * Statistically significant difference (P < 0.05) from mean in 3 lowest quartiles (linear regression analysis, adjusted for smoking and study center); † Statistically significant difference (P < 0.05) from proportion in 3 lowest quartiles (logistic regression analysis, adjusted for sex, age and study center); § Statistically significant difference (P < 0.05) from mean/median in 3 lowest quartiles (linear regression analysis, adjusted for sex, age, smoking and study center). 
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